News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
7,730 Results
Type
Article (629)
Company Profile (3)
Press Release (7098)
Section
Business (2625)
Career Advice (15)
Deals (428)
Drug Delivery (3)
Drug Development (574)
Employer Resources (1)
FDA (100)
Job Trends (217)
News (3595)
Policy (219)
Tag
Academia (37)
Adcomms (1)
Alliances (459)
ALS (2)
Alzheimer's disease (43)
Antibody-drug conjugate (ADC) (5)
Approvals (104)
Artificial intelligence (17)
Autoimmune disease (6)
Automation (1)
Bankruptcy (1)
Best Places to Work (183)
Biosimilars (4)
Biotechnology (2)
Breast cancer (6)
Cancer (77)
Cardiovascular disease (10)
Career advice (15)
CAR-T (3)
Cell therapy (10)
Cervical cancer (3)
Clinical research (483)
Collaboration (28)
Compensation (3)
COVID-19 (27)
CRISPR (6)
C-suite (17)
Cystic fibrosis (1)
Data (71)
Denatured (2)
Depression (6)
Diabetes (14)
Diagnostics (72)
Digital health (3)
Diversity, equity & inclusion (1)
Drug discovery (3)
Drug pricing (3)
Drug shortages (1)
Duchenne muscular dystrophy (31)
Earnings (1505)
Editorial (1)
Employer resources (1)
Events (1062)
Executive appointments (18)
FDA (142)
Frontotemporal dementia (1)
Funding (62)
Gene editing (9)
Generative AI (1)
Gene therapy (12)
GLP-1 (20)
Government (40)
Guidances (10)
Healthcare (249)
Huntington's disease (2)
IgA nephropathy (3)
Immunology and inflammation (14)
Indications (2)
Infectious disease (32)
Inflation Reduction Act (1)
Intellectual property (8)
IPO (225)
IRA (2)
Job creations (35)
Job search strategy (12)
JPM (4)
Labor market (2)
Layoffs (9)
Leadership (3)
Legal (45)
Lung cancer (7)
Lymphoma (5)
Machine learning (1)
Manufacturing (7)
Medical device (148)
Medtech (149)
Mergers & acquisitions (226)
Metabolic disorders (30)
Multiple sclerosis (3)
NASH (1)
Neurodegenerative disease (11)
Neuropsychiatric disorders (3)
Neuroscience (76)
NextGen: Class of 2026 (126)
Non-profit (113)
Obesity (16)
Opinion (13)
Ovarian cancer (2)
Pain (2)
Pancreatic cancer (5)
Parkinson's disease (3)
Partnered (1)
Patents (15)
Patient recruitment (8)
People (700)
Pharmacy benefit managers (1)
Phase 1 (134)
Phase 2 (250)
Phase 3 (200)
Pipeline (204)
Policy (6)
Postmarket research (7)
Preclinical (61)
Press Release (1)
Prostate cancer (3)
Psychedelics (3)
Radiopharmaceuticals (6)
Rare diseases (25)
Real estate (78)
Regulatory (207)
Reports (2)
Research institute (21)
Resumes & cover letters (1)
Rett syndrome (1)
RNA editing (2)
RSV (2)
Schizophrenia (5)
Series A (10)
Series B (5)
Sickle cell disease (5)
Spinal muscular atrophy (6)
Startups (59)
Tariffs (1)
The Weekly (1)
Vaccines (9)
Venture capital (1)
Weight loss (7)
Women's health (1)
Date
Last 7 days (12)
Last 30 days (62)
Last 365 days (624)
2026 (89)
2025 (619)
2024 (652)
2023 (720)
2022 (738)
2021 (637)
2020 (580)
2019 (586)
2018 (405)
2017 (389)
2016 (354)
2015 (410)
2014 (258)
2013 (231)
2012 (195)
2011 (174)
2010 (136)
Location
Africa (9)
Arizona (4)
Arkansas (1)
Asia (325)
Australia (121)
California (187)
Canada (58)
China (8)
Colorado (12)
Connecticut (7)
Delaware (4)
Europe (1131)
Florida (55)
Georgia (4)
Illinois (12)
India (1)
Indiana (8)
Japan (5)
Kansas (2)
Maine (1)
Maryland (16)
Massachusetts (178)
Michigan (3)
Minnesota (12)
Missouri (2)
Nebraska (1)
New Jersey (32)
New York (111)
North Carolina (21)
Northern California (99)
Ohio (5)
Oregon (1)
Pennsylvania (54)
Rhode Island (2)
South America (11)
Southern California (70)
Tennessee (1)
Texas (27)
United States (744)
Utah (11)
Virginia (5)
Washington D.C. (2)
Washington State (11)
Wisconsin (1)
7,730 Results for "catalyst orthoscience".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
The University of Notre Dame and Catalyst Pharmaceuticals Host Inaugural Catalyst Advocacy Scholars Summit (CASS)
January 5, 2026
·
2 min read
Press Releases
Cellectis Announces 2026 Strategy and Catalysts
January 9, 2026
·
7 min read
Business
Catalyst OrthoScience Announces Amy Ables, Ph.D. as Chief Strategy Officer
Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market, has appointed Amy Ables, Ph.D . as chief strategy officer of the organization, effective immediately.
November 20, 2023
·
2 min read
Press Releases
Worldwide Clinical Trials Enters Definitive Agreement to Acquire Catalyst Clinical Research
January 20, 2026
·
5 min read
Press Releases
Opus Genetics Highlights 2025 Progress and Upcoming 2026 Catalysts
January 8, 2026
·
8 min read
Gene therapy
After Mortality-Marred Year, Sarepta Looks Ahead to Catalyst-Rich 2026
Jefferies analysts forecast a $1 billion market opportunity for each of Sarepta’s siRNA programs for facioscapulohumeral muscular dystrophy and myotonic dystrophy type 1.
January 13, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2026 List of America’s Most Successful Small-Cap Companies
January 8, 2026
·
2 min read
Press Releases
Catalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference
December 16, 2025
·
2 min read
Press Releases
Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference
November 24, 2025
·
2 min read
Business
Catalyst OrthoScience Announces Mark Quick as Chief Financial Officer
Catalyst OrthoScience Inc., a medical device company focused on the upper extremity orthopedics market, has appointed seasoned medical device leader Mark Quick as chief financial officer of the organization, effective immediately.
June 6, 2023
·
2 min read
1 of 773
Next
